Mark E. Bunnage
EVP, Chief Scientific Officer · 1 filing · Latest: May 15, 2026
VERTEX PHARMACEUTICALS INC / MA
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
VRTX | Mark E. Bunnage | EVP, Chief Scientific Officer | May 15, 2026 | Sale | $453.45 | 33 | $15.0K | 7,284 |